ALS Gene Therapy Approved for Global Trials in China and U.S.
15 Aug 2025 //
PR NEWSWIRE
SineuGene`s SNUG01 Receives FDA Orphan Drug Designation for ALS
26 Jun 2025 //
PR NEWSWIRE
SineuGene Therapeutics gets FDA clearance for ALS gene therapy
25 Mar 2025 //
PR NEWSWIRE

Market Place
Sourcing Support